Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 May 7.
doi: 10.1111/jdv.16587. Online ahead of print.

Evolution of COVID-19 Infection in 4 Psoriatic Patients Treated With Biological Drugs

Affiliations

Evolution of COVID-19 Infection in 4 Psoriatic Patients Treated With Biological Drugs

A Conti et al. J Eur Acad Dermatol Venereol. .

Abstract

Since December 2019, the pandemic coronavirus disease (2019-nCoV; COVID-19) has changed the approach to all dermatological diseases; in particular, psoriatic patients undergoing immunosuppressive drugs, such as biologics, can potentially show an increase risk of infection (1). However, few reports are available on the course of COVID-19 infection in psoriatic patients treated with biological drugs (2). We describe a case series of four psoriatic patients treated with biologics who had a risk contact with COVID-19.

Keywords: SARS-CoV-2; covid-19; psoriasis; biologic; therapies.

Similar articles

See all similar articles

LinkOut - more resources

Feedback